Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Scientists say they succeeded for the first time in wiping out an entire population of malaria-carrying mosquitos in the lab using a gene editing tool to programme their extinction.

Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...

Prime Video’s Fallout Season 2 Episode 4 finally gave fans what they have been waiting for since day one: Deathclaws, in all their terrifying, live-action glory.

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

American philosopher Quine wrote, “As an empiricist I continue to think of the conceptual scheme of science as a tool, ...

Biju Dharmapalan [email protected] As the world steps into 2026, science is no longer a quiet enterprise unfolding ...

Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy: Berlin, Germany Friday, January 9, 2026, 09:00 Hrs [IST] Bayer a ...

A new study has identified the first known gene in eggplant that provides resistance to begomoviruses, a group of plant viruses responsible for major crop losses worldwide. The research shows that ...